Last update 25 Aug 2025

YM-22561

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
YM 22561, YM22561
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Escherichia Coli InfectionsStaphylococcus Aureus InfectionsStreptococcal Infections
Originator Organization
Yamanouchi Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Yamanouchi Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC19H21N5O7S4
InChIKeyPANJOVNIUABIDZ-AIALHPKPSA-N
CAS Registry135356-93-3

Related

100 Clinical Results associated with YM-22561
Login to view more data
100 Translational Medicine associated with YM-22561
Login to view more data
100 Patents (Medical) associated with YM-22561
Login to view more data
1
Literatures (Medical) associated with YM-22561
01 Jan 1991The Journal of antibioticsQ4 · MEDICINE
Studies on .BETA.-lactam antibiotics. III. Syntheses and antibacterial activities of new 3-(1,3-dithiolan-2-yl)cephalosporins, ym-22508, ym-16457 and their prodrug-type esters.
Q4 · MEDICINE
100 Deals associated with YM-22561
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Escherichia Coli InfectionsPreclinical
Japan
Yamanouchi Pharmaceutical Co., Ltd.
01 Jan 1991
Staphylococcus Aureus InfectionsPreclinical
Japan
Yamanouchi Pharmaceutical Co., Ltd.
01 Jan 1991
Streptococcal InfectionsPreclinical
Japan
Yamanouchi Pharmaceutical Co., Ltd.
01 Jan 1991
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free